|
Ticagrelor 90 mg Clinical Trials
3 actively recruiting trials across 2 locations
Also known as: Brilinta
Pipeline
Phase 3: 1Phase 4: 2
Top Sponsors
- Weill Medical College of Cornell University1
- University of Florida1
- Shiraz University of Medical Sciences1
Indications
- Heart Disease3
- Coronary Artery Disease2
- Chronic Coronary Disease1
Other1 trial
Phase 4
Jacksonville, Florida1 trial
Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors
University of Florida Jacksonville
Phase 4
Englewood, New Jersey1 trial
One-Month DAPT in CABG Patients
Englewood Hospital
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.